Doctor profile · Federal record
Dr. Ralph Boccia, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Bethesda, MD
- NPI 1881663284
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 49 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6410 Rockledge Dr, Suite 660
Bethesda, MD 208171809
(301) 571-0019
fax (301) 571-0988 - Mailing address
-
Po Box 749488
Atlanta, GA 303749488
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- January 3, 2023
- Year of graduation
- 1977 — 49 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D29675
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881663284. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
230,314
Distinct HCPCS
10
Medicare allowed
$3,207,078
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 88,230 | 82 | $1 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 29,100 | 12 | $0 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 27,850 | 98 | $7 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 24,120 | 12 | $45 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 18,808 | 27 | $45 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 8,400 | 69 | $20 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 7,200 | 21 | $3 | |
J0897 |
Injection, denosumab, 1 mg | 6,780 | 51 | $23 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 3,244 | 731 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 3,153 | 723 | $8 |
In context: peer comparison
Among 2 peers in Bethesda Hematology & Oncology Physician, average services per provider: 4,757. This provider delivers 48× the peer median.Open Payments
Industry payments received
All-time total
$430,532
Transactions
311
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Fennec Pharmaceuticals, INC. | 20 | $102,510.93 | |
| Pharmacosmos Therapeutics INC. | 37 | $48,193.83 | |
| Sobi, INC | 31 | $37,747.26 | |
| Janssen Biotech, INC. | 43 | $34,768.71 | |
| BeiGene USA, INC. | 21 | $31,765.20 | |
| Regeneron Healthcare Solutions, INC. | 28 | $29,282.03 | |
| Abbvie INC. | 26 | $28,330.00 | |
| Karyopharm Therapeutics INC. | 12 | $19,451.00 | |
| Genmab U.S., INC. | 14 | $18,270.79 | |
| Daiichi Sankyo INC. | 26 | $13,495.96 | |
| Stemline Therapeutics INC. | 8 | $12,085.98 | |
| Genzyme Corporation | 12 | $11,483.84 | |
| Rigel Pharmaceuticals, INC. | 14 | $8,743.95 | |
| Celgene Corporation | 16 | $7,228.26 | |
| Amgen INC. | 3 | $5,421.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
590
Patients
71
Total drug cost
$3,857,166
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 84 | 17 | $67,680 |
| Revlimid (Lenalidomide) | Brand | 67 | 13 | $1,144,963 |
| Gabapentin | Generic | 57 | 11 | $717 |
| Calquence (Acalabrutinib Maleate) | Brand | 51 | 0 | $806,968 |
| Xarelto (Rivaroxaban) | Brand | 51 | 17 | $60,924 |
| Dexamethasone | Generic | 50 | 13 | $1,085 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 44 | 0 | $752,977 |
| Acyclovir | Generic | 30 | 0 | $430 |
| Letrozole | Generic | 29 | 0 | $1,110 |
| Brukinsa (Zanubrutinib) | Brand | 25 | 0 | $385,311 |
Frequently asked questions
What is Dr. Ralph Boccia's medical specialty?
Dr. Ralph Boccia practices Hematology & Oncology Physician in Bethesda, MD.
Where does Dr. Ralph Boccia practice?
Dr. Ralph Boccia practices at 6410 Rockledge Dr, Bethesda, MD 208171809. Office phone: 3015710019.
What is Dr. Ralph Boccia's NPI?
Dr. Ralph Boccia's National Provider Identifier (NPI) is 1881663284, issued by NPPES.
Does Dr. Ralph Boccia accept Medicare assignment?
Yes. Dr. Ralph Boccia accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ralph Boccia commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS J0885). Source: CMS Medicare Physician & Other Practitioners file.